Authors: FRIDRIK MA GREIL R HAUSMANINGER H KRIEGER O OPPITZ P STOGER M KLOCKER J NEUBAUER M HELM W PONT J FAZENY B HUDEC M SIMONITSCH I RADASZKIEWICZ T

Citation: Ma. Fridrik et al., RANDOMIZED OPEN-LABEL PHASE-III TRIAL OF CEOP IMVP-DEXA ALTERNATING CHEMOTHERAPY AND FILGRASTIM VERSUS CEOP/IMVP-DEXA ALTERNATING CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - A MULTICENTER TRIAL BY THE AUSTRIAN WORKING GROUP FOR MEDICAL TUMOR-THERAPY/, Annals of hematology, 75(4), 1997, pp. 135-140

Authors: FAZENY B BAUR M PROHASKA M HUDEC M KREMNITZER M MERYN S HUBER H GRUNT T TUCHMANN A DITTRICH C

Citation: B. Fazeny et al., OCTREOTIDE COMBINED WITH GOSERELIN IN THE THERAPY OF ADVANCED PANCREATIC-CANCER - RESULTS OF A PILOT-STUDY AND REVIEW OF THE LITERATURE, Journal of cancer research and clinical oncology, 123(1), 1997, pp. 45-52

Authors: ANTOLJAK T HANCEVIC J NIKOLIC V HUDEC M JOVANOVIC V TURCIC J

Citation: T. Antoljak et al., COMPARISON OF CONTACT PARAMETERS BETWEEN THE PROXIMAL HUMERUS AND THEACROMION WITH HERTZS THEORETICAL-MODEL, Collegium antropologicum, 19(2), 1995, pp. 431-439

Authors: DITTRICH C BAUR M VAVRA N HUDEC M FAZENY B BARRADA M SALZER H SEVELDA P

Citation: C. Dittrich et al., ETOPOSIDE AND CARBOPLATIN AS SALVAGE AND 1ST-LINE THERAPY IN OVARIAN-CANCER PATIENTS, Annals of oncology, 4(8), 1993, pp. 697-699

Authors: DITTRICH C SEVELDA P BAUR M MARTH C HUDEC M VAVRA N GRUNT T FAZENY B SALZER H

Citation: C. Dittrich et al., INVITRO AND INVIVO EVALUATION OF THE COMBINATION OF CISPLATIN AND ITSANALOG CARBOPLATIN FOR PLATINUM DOSE INTENSIFICATION IN OVARIAN-CARCINOMA, Cancer, 71(10), 1993, pp. 3082-3090